CD8A and neoplasm: In this case, their expansion to up to 80% of the peripheral CD8+ T cells would cause an overall reduction of the CD8+ T cell antigenic repertoire (including potential anti-tumor specificities) that could also be linked to poorer CD8+ T cell responses [27].